Abstract | BACKGROUND: Children and adolescents with leukemia are potentially at high risk of vitamin D inadequacy, which may have clinical relevance for skeletal morbidity, infections, and cancer outcome. This study aimed to evaluate vitamin D status at the time of diagnosis to investigate its predictors and association with overall survival in children with leukemia. PROCEDURE: We included all 295 children and adolescents diagnosed with leukemia at our institution between 1990 and 2016 who had available serum sample from the time of diagnosis. We analyzed serum 25-hydroxyvitamin D and parathyroid hormone levels and correlated them with clinical data. RESULTS: The 25-hydroxyvitamin D level was deficient (< 25 nmol/L), insufficient (25-50 nmol/L), sufficient (50-75 nmol/L), and optimal (> 75 nmol/L) in 6.4%, 26.8%, 39.7%, and 27.1% of the children, respectively. Older age and a more recent time of sampling (calendar year) predicted lower 25-hydroxyvitamin D level. In preschool children (age ≤6 years), lower 25-hydroxyvitamin D level was also associated with acute myeloid leukemia, and a 25-hydroxyvitamin D level < 50 nmol/L was associated with inferior overall survival. In school-aged children (age > 6 years), the 25-hydroxyvitamin D level showed significant seasonal variation. CONCLUSION: It remains unclear whether vitamin D supplementation in pediatric leukemia patients will improve outcome.
|
Authors | Natalja Jackmann, Outi Mäkitie, Arja Harila-Saari, Jan Gustafsson, Dzeneta Nezirevic Dernroth, Per Frisk |
Journal | Pediatric blood & cancer
(Pediatr Blood Cancer)
Vol. 67
Issue 4
Pg. e28163
(04 2020)
ISSN: 1545-5017 [Electronic] United States |
PMID | 31925904
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 Wiley Periodicals, Inc. |
Chemical References |
- Vitamin D
- 25-hydroxyvitamin D
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Cross-Sectional Studies
- Female
- Follow-Up Studies
- Humans
- Incidence
- Infant
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(blood, epidemiology, mortality)
- Leukemia, Myeloid, Acute
(blood, epidemiology, mortality)
- Leukemia, Myelomonocytic, Juvenile
(blood, epidemiology, mortality)
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(blood, epidemiology, mortality)
- Prognosis
- Retrospective Studies
- Seasons
- Survival Rate
- Sweden
(epidemiology)
- Vitamin D
(analogs & derivatives, blood)
- Vitamin D Deficiency
(physiopathology)
|